RecruitingNCT06668519

Magnetoencephalography in Children

An Observational Study on the Clinical Application of Magnetoencephalography in Children With Neurodevelopmental Disorders

Sponsor

Children's Hospital of Fudan University

Enrollment

1,500 participants

Start Date

Sep 25, 2024

Study Type

OBSERVATIONAL

Conditions

Epilepsy Autism Cerebrovascular Disease Intracranial Tumors ADHD - Attention Deficit Disorder With Hyperactivity Neuropsychiatric Disorders Tic Disorder, Childhood Mental Retardation Developmental Disabilities

Summary

This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.

Eligibility

Min Age: 1 MonthMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study uses a brain imaging technique called magnetoencephalography (MEG) — which measures tiny magnetic signals produced by brain activity — to better understand neurological and developmental conditions in children. It is an observational study, meaning no new treatments are given. **You may be eligible if...** - You are between 1 month and 18 years old - You have one of the following conditions: epilepsy, a brain tumor, a blood vessel problem in the brain, autism, intellectual disability, ADHD, tic disorder, or another neuropsychiatric condition **You may NOT be eligible if...** - You are unable to cooperate with the MEG scan Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.